MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht - Downloaded Version 2027.0.0-ballot.1 See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "mii-exa-befund-bundle-befund-fgfr2-fusion",
"language" : "de",
"type" : "transaction",
"timestamp" : "2022-12-16T13:47:00+01:00",
"entry" : [
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion",
"resource" : {
"resourceType" : "Patient",
"id" : "mii-exa-molgen-patient-fgfr2-fusion",
"language" : "de",
"text" : {
"status" : "generated"
},
"identifier" : [
{
"use" : "usual",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationValue",
"code" : "PSEUDED"
}
]
},
"system" : "https://www.charite.de/fhir/sid/pseudonym",
"value" : "3337167192"
}
],
"gender" : "female",
"birthDate" : "1964-05",
"deceasedBoolean" : false,
"address" : [
{
"type" : "both",
"postalCode" : "10",
"country" : "DE"
}
]
},
"request" : {
"method" : "PUT",
"url" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab",
"resource" : {
"resourceType" : "Practitioner",
"id" : "mii-exa-molgen-practitioner-lab",
"language" : "de",
"text" : {
"status" : "generated"
},
"active" : true,
"name" : [
{
"use" : "official",
"text" : "Dr. Daniel Schmidt",
"family" : "Schmidt",
"given" : [
"Daniel"
],
"prefix" : [
"Dr."
]
}
]
},
"request" : {
"method" : "PUT",
"url" : "Practitioner/mii-exa-molgen-practitioner-lab"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician",
"resource" : {
"resourceType" : "Practitioner",
"id" : "mii-exa-molgen-practitioner-physician",
"language" : "de",
"text" : {
"status" : "generated"
},
"active" : true,
"name" : [
{
"use" : "official",
"text" : "Dr. Linda Rubens",
"family" : "Rubens",
"given" : [
"Linda"
],
"prefix" : [
"Dr."
]
}
]
},
"request" : {
"method" : "PUT",
"url" : "Practitioner/mii-exa-molgen-practitioner-physician"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-befundbericht-fgfr2-fusion",
"resource" : {
"resourceType" : "DiagnosticReport",
"id" : "mii-exa-molgen-befundbericht-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/molekulargenetischer-befundbericht|2027.0.0-ballot.1"🔗 ,
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report|3.0.0"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action",
"valueReference" : {
🔗 "reference" : "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
}
}
],
"basedOn" : [
{
🔗 "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "GE",
"display" : "Genetics"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "51969-4",
"display" : "Genetic analysis report"
}
]
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"performer" : [
{
🔗 "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"result" : [
{
🔗 "reference" : "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
},
{
🔗 "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
},
{
🔗 "reference" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
],
"conclusion" : "Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie."
},
"request" : {
"method" : "PUT",
"url" : "DiagnosticReport/mii-exa-molgen-befundbericht-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion",
"resource" : {
"resourceType" : "ServiceRequest",
"id" : "mii-exa-molgen-anforderung-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"identifier" : [
{
"system" : "https://www.charite.de/fhir/auftragsnummern",
"value" : "PRK4QE59A"
}
],
"status" : "active",
"intent" : "order",
"category" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "108252007",
"display" : "Laboratory procedure (procedure)"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "405825005",
"display" : "Molecular genetic test (procedure)"
}
],
"text" : "Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"authoredOn" : "2022-11-30",
"requester" : {
🔗 "reference" : "Practitioner/mii-exa-molgen-practitioner-physician"
},
"reasonCode" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "109842005",
"display" : "Intrahepatic bile duct carcinoma (disorder)"
},
{
"system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
"version" : "2024",
"code" : "C22.1",
"display" : "Intrahepatisches Gallengangskarzinom"
}
]
}
]
},
"request" : {
"method" : "PUT",
"url" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion",
"resource" : {
"resourceType" : "Observation",
"id" : "mii-exa-molgen-variante-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/variante|2027.0.0-ballot.1"🔗 ,
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant|3.0.0"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"basedOn" : [
{
🔗 "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/observation-category",
"code" : "laboratory",
"display" : "Laboratory"
}
]
},
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "GE"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "69548-6",
"display" : "Genetic variant assessment"
}
]
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime" : "2022-11-30",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "LA9633-4",
"display" : "Present"
}
]
},
"method" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "LA26398-0",
"display" : "Sequencing"
},
{
"system" : "http://loinc.org",
"code" : "86206-0",
"display" : "Whole genome sequence analysis in Blood or Tissue by Molecular genetics method"
}
]
},
"component" : [
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "48018-6"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://www.genenames.org/geneId",
"code" : "HGNC:3689",
"display" : "FGFR2"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "48019-4"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://sequenceontology.org",
"code" : "SO:0001565",
"display" : "gene_fusion"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "95123-6"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://www.genenames.org/geneId",
"code" : "HGNC:3689::HGNC:2697",
"display" : "FGFR2::DBP"
}
]
}
}
]
},
"request" : {
"method" : "PUT",
"url" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
"resource" : {
"resourceType" : "Observation",
"id" : "mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/diagnostische-implikation|2027.0.0-ballot.1"🔗 ,
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/diagnostic-implication|3.0.0"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/observation-category",
"code" : "laboratory",
"display" : "Laboratory"
}
]
},
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "GE"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code" : "diagnostic-implication",
"display" : "Diagnostic Implication"
}
]
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime" : "2022-11-30",
"performer" : [
{
🔗 "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"derivedFrom" : [
{
🔗 "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
],
"component" : [
{
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code" : "conclusion-string"
}
]
},
"valueString" : "starke Überexpression (25-fach)"
}
]
},
"request" : {
"method" : "PUT",
"url" : "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
"resource" : {
"resourceType" : "Observation",
"id" : "mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation|2027.0.0-ballot.1"🔗 ,
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication|3.0.0"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/observation-category",
"code" : "laboratory",
"display" : "Laboratory"
}
]
},
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "GE"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code" : "therapeutic-implication",
"display" : "Therapeutic Implication"
}
]
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime" : "2022-11-30",
"performer" : [
{
🔗 "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"derivedFrom" : [
{
🔗 "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
],
"component" : [
{
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code" : "conclusion-string"
}
]
},
"valueString" : "Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "51963-7",
"display" : "Medication assessed [ID]"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "L01EN",
"display" : "Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"
},
{
"system" : "http://snomed.info/sct",
"code" : "1162485005",
"display" : "Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "93044-6"
}
]
},
"valueCodeableConcept" : {
"text" : "m1c"
}
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "81259-4"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "109842005",
"display" : "Intrahepatic bile duct carcinoma (disorder)"
},
{
"system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
"version" : "2024",
"code" : "C22.1",
"display" : "Intrahepatisches Gallengangskarzinom"
}
]
}
}
]
},
"request" : {
"method" : "PUT",
"url" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
},
{
"fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
"resource" : {
"resourceType" : "Task",
"id" : "mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2027.0.0-ballot.1"🔗 ,
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"
]
},
"language" : "de",
"text" : {
"status" : "generated"
},
"basedOn" : [
{
🔗 "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status" : "requested",
"intent" : "proposal",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "LA26421-0",
"display" : "Consider alternative medication"
}
],
"text" : "Hochselektive FGFR-Inhibitor-Therapie"
},
"for" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"reasonReference" : {
🔗 "reference" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
},
"request" : {
"method" : "PUT",
"url" : "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
}
}
]
}